![Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine](https://www.thelancet.com/cms/attachment/49e98917-4058-4b9d-a18b-1d4d8f67ab34/gr2_lrg.jpg)
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine
![JCM | Free Full-Text | Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference JCM | Free Full-Text | Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference](https://www.mdpi.com/jcm/jcm-10-01507/article_deploy/html/images/jcm-10-01507-g004.png)
JCM | Free Full-Text | Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference
![Assessment of Hepatic Steatosis in Patients with Chronic Hepatitis B Using Fibroscan and its Relation to Insulin Resistance Assessment of Hepatic Steatosis in Patients with Chronic Hepatitis B Using Fibroscan and its Relation to Insulin Resistance](https://openbiomarkerjournal.com/contents/volumes/V9/TOBIOMJ-9-70/TOBIOMJ-9-70_F2.jpg)
Assessment of Hepatic Steatosis in Patients with Chronic Hepatitis B Using Fibroscan and its Relation to Insulin Resistance
![Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery | Scientific Reports Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-93294-6/MediaObjects/41598_2021_93294_Fig1_HTML.png)
Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery | Scientific Reports
![Frontiers | Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement Frontiers | Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement](https://www.frontiersin.org/files/Articles/739875/fendo-12-739875-HTML/image_m/fendo-12-739875-g001.jpg)
Frontiers | Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement
![Fibro-Scan results. The device computer interprets data obtained from... | Download Scientific Diagram Fibro-Scan results. The device computer interprets data obtained from... | Download Scientific Diagram](https://www.researchgate.net/publication/304070536/figure/fig3/AS:374313254440961@1466254642088/Fibro-Scan-results-The-device-computer-interprets-data-obtained-from-any-measurement-and.png)
Fibro-Scan results. The device computer interprets data obtained from... | Download Scientific Diagram
![Results of Fibroscan, CAP, NAFLD Fibrosis Score, FIB 4, and FAST Score... | Download Scientific Diagram Results of Fibroscan, CAP, NAFLD Fibrosis Score, FIB 4, and FAST Score... | Download Scientific Diagram](https://www.researchgate.net/publication/369058423/figure/tbl3/AS:11431281125190786@1678229958221/Results-of-Fibroscan-CAP-NAFLD-Fibrosis-Score-FIB-4-and-FAST-Score-in-NAFLD-Group.png)